Bavencio (avelumab), a PD-L1-inhibitor, gained approval by the Food and Drug Administration (FDA) for some patients with Merkel cell carcinoma.
Sara Hurvitz, M.D. talks about recent and upcoming advancements in the treatment of HER2-positive breast cancer
Kiran K. Turaga explains that, even with all the advancements and novel treatments in melanoma, surgery is still critical.
Experimental treatment uses engineered T cells to target prostate stem cell antigen.
The NCCN created new free, online resources for patients with cancer who are experiencing distress.
John E. Mullinax, M.D., discusses a chemotherapy strategy that may be able to save the limbs of some patients with sarcoma.
As researchers test new treatments for GBM, understanding the unique needs of patients with this diagnosis and their caregivers remains crucial.
Whether a cancer arises on the left or right side of the colon can affect both prognosis and treatment.
A recent study found that individuals who had the chickenpox virus when they were younger were less likely to eventually develop gliomas.